Nautilus Biotechnology (NAUT) Prepaid Assets (2020 - 2026)
Nautilus Biotechnology (NAUT) reported Prepaid Assets of $3.0 million for Q1 2026, up 6.16% on a YoY basis from $2.8 million in Q1 2025, and up 15.88% sequentially from $2.6 million in Q4 2025.
Nautilus Biotechnology (NAUT) Prepaid Assets (2020 - 2026) Analysis & Trends
Nautilus Biotechnology (NAUT) has 7 years of Prepaid Assets data on file, last reported at $3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 6.16% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (up 6.16% YoY), and the FY2025 full-year result was $2.6 million, down 12.82% from the prior year.
- Prepaid Assets grew to $3.0 million in Q1 2026, from $2.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.1 million in Q2 2022 to a low of $2.6 million in Q4 2025.
- A 5-year average of $3.2 million and a median of $3.1 million in 2023 frame the typical range for Prepaid Assets.
- Peak annual rise in Prepaid Assets reached 1062.32% in 2022, while the deepest fall reached 33.28% in 2022.
- Tracing NAUT's Prepaid Assets over 5 years: stood at $2.7 million in 2022, then climbed by 24.87% to $3.4 million in 2023, then fell by 14.21% to $2.9 million in 2024, then slipped by 12.82% to $2.6 million in 2025, then grew by 15.88% to $3.0 million in 2026.
- Business Quant data shows NAUT's Prepaid Assets at $3.0 million in Q1 2026, $2.6 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nautilus Biotechnology | 224.14 Mn | 224.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.96 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 2.93 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 3.41 Mn |
| Mar 31, 2023 | 3.14 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Sep 30, 2022 | 3.25 Mn |
| Jun 30, 2022 | 4.11 Mn |
| Mar 31, 2022 | 2.95 Mn |
| Dec 31, 2021 | 3.49 Mn |
| Sep 30, 2021 | 4.88 Mn |
| Jun 30, 2021 | 1.48 Mn |